SG

Scott Gangloff

Chief Technical Officer

Akero Therapeutics

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Akero Therapeutics
Industry
research
Employees
70.0
Seniority
C suite

Professional Summary

Scott Gangloff serves as Chief Technical Officer at Akero Therapeutics. Akero Therapeutics operates in the research sector with approximately 70.0 employees. The company is headquartered in New York, New York.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • We have verified contacts for 2 executives at Akero Therapeutics.
  • 6,952 executive contacts are available in New York.
  • Our database includes 201,469 c suite-level executives.

Technologies

NetSuite Mimecast New Relic Mobile Friendly Google Maps reCAPTCHA Google Tag Manager Akamai RUM Vimeo WordPress.org Gravity Forms Google Font API Google Analytics Remote AI

Keywords

biotechnology: pharmaceutical preparations health care biotechnology research metabolic diseases efruxifermin mash biopharmaceutical clinical trials therapeutic areas investigational drug research programs expanded access translational medicine drug development liver disease metabolic dysfunction fc-fgf21 fusion protein clinical development biotechnology unmet medical need novel therapies patient outcomes clinical stage pipeline biotechnology company cholesterol management liver health drug commercialization investor relations medical affairs regulatory affairs therapeutic innovation clinical research patient-centric personalized medicine fda approved breakthrough therapy safety & efficacy biomarkers scientific expertise collaborative culture science-driven healthcare conferences stock information corporate governance quality assurance strategic partnerships funding investments market potential commercial strategy healthcare investment clinical research operations physician-scientist clinical-stage biotechnology innovative treatments metabolic dysfunction-associated steatohepatitis non-alcoholic steatohepatitis fgf21 fusion protein liver fibrosis chronic liver disease transformative therapies high unmet medical needs metabolic disorders collaboration scientific innovation financial stability biopharmaceutical sector healthcare providers obesity type 2 diabetes cirrhosis therapeutic focus competitive edge partnerships collaborations health wellness & fitness hospital & health care

Related Executives

KY
Kitty Yale EVP and Chief Development Officer at Akero Therapeutics
SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma

Frequently Asked Questions

How can I contact Scott Gangloff?

Scott Gangloff's verified email address is available on MessageCEO. They currently work at Akero Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Scott Gangloff lead?

Scott Gangloff is Chief Technical Officer at Akero Therapeutics, a company in the research sector with 70.0 employees. The company is based in New York, New York.

What industry is Scott Gangloff in?

Scott Gangloff works in the research industry as Chief Technical Officer at Akero Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Scott Gangloff's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Scott Gangloff's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 7, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans